1IA
LLY icon

1834 Investment Advisors’s Eli Lilly LLY Stock Holding History

1834 Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.92M Sell
3,175
-20
-0.6% -$20.3K 0.36% 68
2025
Q4 		$3.43M Sell
3,195
-56
-2% -$53.5K 0.43% 63
2025
Q3 		$2.48M Sell
3,251
-115
-3% -$85.6K 0.3% 75
2025
Q2 		$2.62M Hold
3,366
– – 0.33% 70
2025
Q1 		$2.78M Sell
3,366
-135
-4% -$112K 0.36% 67
2024
Q4 		$2.7M Sell
3,501
-37
-1% -$30.6K 0.34% 72
2024
Q3 		$3.13M Sell
3,538
-808
-19% -$726K 0.36% 70
2024
Q2 		$3.94M Sell
4,346
-55
-1% -$44K 0.47% 61
2024
Q1 		$3.42M Sell
4,401
-45
-1% -$32K 0.41% 67
2023
Q4 		$2.59M Sell
4,446
-258
-5% -$151K 0.31% 73
2023
Q3 		$2.53M Buy
4,704
+150
+3% +$77.3K 0.31% 76
2023
Q2 		$2.14M Sell
4,554
-1,926
-30% -$808K 0.25% 80
2023
Q1 		$2.23M Buy
6,480
+1,788
+38% +$603K 0.27% 82
2022
Q4 		$1.72M Buy
4,692
+100
+2% +$35.5K 0.25% 76
2022
Q3 		$1.49M Sell
4,592
-64
-1% -$20.3K 0.22% 80
2022
Q2 		$1.51M Sell
4,656
-64
-1% -$19.2K 0.21% 79
2022
Q1 		$1.35M Sell
4,720
-183
-4% -$47.1K 0.17% 90
2021
Q4 		$1.35M Sell
4,903
-2
-0% -$507 0.15% 93
2021
Q3 		$1.13M Sell
4,905
-125
-2% -$30.9K 0.14% 101
2021
Q2 		$1.15M Sell
5,030
-404
-7% -$81.2K 0.14% 101
2021
Q1 		$1.01M Sell
5,434
-175
-3% -$34.2K 0.13% 94
2020
Q4 		$947K Hold
5,609
– – 0.13% 92
2020
Q3 		$830K Sell
5,609
-150
-3% -$23.2K 0.12% 96
2020
Q2 		$945K Buy
5,759
+29
+0.5% +$4.45K 0.15% 88
2020
Q1 		$795K Sell
5,730
-46
-0.8% -$6.32K 0.15% 90
2019
Q4 		$759K Buy
5,776
+237
+4% +$27.5K 0.12% 101
2019
Q3 		$619K Hold
5,539
– – 0.09% 112
2019
Q2 		$614K Hold
5,539
– – 0.09% 106
2019
Q1 		$719K Sell
5,539
-50
-0.9% -$6.08K 0.11% 106
2018
Q4 		$647K Sell
5,589
-310
-5% -$34.6K 0.11% 111
2018
Q3 		$633K Sell
5,899
-185
-3% -$18.5K 0.09% 115
2018
Q2 		$519K Sell
6,084
-1,651
-21% -$136K 0.08% 118
2018
Q1 		$598K Hold
7,735
– – 0.1% 113
2017
Q4 		$653K Sell
7,735
-100
-1% -$8.51K 0.1% 119
2017
Q3 		$670K Sell
7,835
-38
-0.5% -$3.12K 0.13% 102
2017
Q2 		$648K Buy
7,873
+115
+1% +$9.38K 0.12% 109
2017
Q1 		$653K Sell
7,758
-50
-0.6% -$4K 0.13% 108
2016
Q4 		$574K Hold
7,808
– – 0.12% 112
2016
Q3 		$627K Sell
7,808
-150
-2% -$12K 0.14% 106
2016
Q2 		$627K Hold
7,958
– – 0.14% 117
2016
Q1 		$573K Sell
7,958
-493
-6% -$37.3K 0.13% 114
2015
Q4 		$712K Sell
8,451
-300
-3% -$24.9K 0.17% 107
2015
Q3 		$732K Sell
8,751
-60
-0.7% -$5.07K 0.18% 105
2015
Q2 		$736K Sell
8,811
-487
-5% -$37.1K 0.2% 92
2015
Q1 		$675K Sell
9,298
-100
-1% -$7.12K 0.18% 101
2014
Q4 		$648K Sell
9,398
-22
-0.2% -$1.49K 0.18% 99
2014
Q3 		$611K Sell
9,420
-127
-1% -$8.04K 0.17% 102
2014
Q2 		$594K Hold
9,547
– – 0.16% 105
2014
Q1 		$562K Sell
9,547
-1,219
-11% -$68K 0.16% 100
2013
Q4 		$549K Sell
10,766
-1,200
-10% -$60.1K 0.16% 103
2013
Q3 		$602K Sell
11,966
-477
-4% -$25K 0.2% 91
2013
Q2 		$611K Buy
+12,443
New +$677K 0.21% 91

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

1834 Investment Advisors's LLY Position: Q1 2026 in Review

1834 Investment Advisors reduced its Eli Lilly (LLY) stake by 0.63% in Q1 2026, selling an estimated $20.3K and leaving 3,175 shares worth $2.92M. The position accounts for 0.36% of the portfolio, ranked #68.

1834 Investment Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.94M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • 1834 Investment Advisors held 3,175 shares of Eli Lilly worth $2.92M as of Q1 2026.
  • 1834 Investment Advisors sold 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
  • Eli Lilly made up 0.36% of 1834 Investment Advisors's portfolio in Q1 2026, its #68 holding.
  • 1834 Investment Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • 1834 Investment Advisors's Eli Lilly position peaked at $3.94M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on 1834 Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.